Skip to main content
. 2016 Oct 19;11(10):e0163350. doi: 10.1371/journal.pone.0163350

Fig 1. Study flow diagram; core and extension study phases.

Fig 1

IDegIAsp, insulin degludec/insulin aspart; IGlar, insulin glargine (U100); OD, once daily; n, number of participants.